CH657530A5 - Stabilisierte insulinloesungen und verfahren zu ihrer herstellung. - Google Patents

Stabilisierte insulinloesungen und verfahren zu ihrer herstellung. Download PDF

Info

Publication number
CH657530A5
CH657530A5 CH657/83A CH65783A CH657530A5 CH 657530 A5 CH657530 A5 CH 657530A5 CH 657/83 A CH657/83 A CH 657/83A CH 65783 A CH65783 A CH 65783A CH 657530 A5 CH657530 A5 CH 657530A5
Authority
CH
Switzerland
Prior art keywords
insulin
zinc
solution according
solution
hexamer
Prior art date
Application number
CH657/83A
Other languages
German (de)
English (en)
Inventor
Jens Jorgen Vejlgaard Brange
Svend Havelund
Original Assignee
Novo Industri As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Industri As filed Critical Novo Industri As
Publication of CH657530A5 publication Critical patent/CH657530A5/de

Links

Classifications

    • H—ELECTRICITY
    • H05—ELECTRIC TECHNIQUES NOT OTHERWISE PROVIDED FOR
    • H05K—PRINTED CIRCUITS; CASINGS OR CONSTRUCTIONAL DETAILS OF ELECTRIC APPARATUS; MANUFACTURE OF ASSEMBLAGES OF ELECTRICAL COMPONENTS
    • H05K13/00—Apparatus or processes specially adapted for manufacturing or adjusting assemblages of electric components
    • H05K13/06—Wiring by machine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Manufacturing & Machinery (AREA)
  • Microelectronics & Electronic Packaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
CH657/83A 1982-02-05 1983-02-04 Stabilisierte insulinloesungen und verfahren zu ihrer herstellung. CH657530A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK49182 1982-02-05

Publications (1)

Publication Number Publication Date
CH657530A5 true CH657530A5 (de) 1986-09-15

Family

ID=8094159

Family Applications (1)

Application Number Title Priority Date Filing Date
CH657/83A CH657530A5 (de) 1982-02-05 1983-02-04 Stabilisierte insulinloesungen und verfahren zu ihrer herstellung.

Country Status (22)

Country Link
US (1) US4476118A (cg-RX-API-DMAC10.html)
JP (1) JPS58192818A (cg-RX-API-DMAC10.html)
AT (1) AT382780B (cg-RX-API-DMAC10.html)
AU (1) AU549981B2 (cg-RX-API-DMAC10.html)
BE (1) BE895832A (cg-RX-API-DMAC10.html)
CA (1) CA1203476A (cg-RX-API-DMAC10.html)
CH (1) CH657530A5 (cg-RX-API-DMAC10.html)
DE (1) DE3303860A1 (cg-RX-API-DMAC10.html)
ES (1) ES8500060A1 (cg-RX-API-DMAC10.html)
FI (1) FI78616C (cg-RX-API-DMAC10.html)
FR (1) FR2521009B1 (cg-RX-API-DMAC10.html)
GB (1) GB2114573B (cg-RX-API-DMAC10.html)
GR (1) GR77388B (cg-RX-API-DMAC10.html)
IE (1) IE54548B1 (cg-RX-API-DMAC10.html)
IT (1) IT1178455B (cg-RX-API-DMAC10.html)
LU (1) LU84632A1 (cg-RX-API-DMAC10.html)
NL (1) NL187269C (cg-RX-API-DMAC10.html)
NO (1) NO161204C (cg-RX-API-DMAC10.html)
NZ (1) NZ203189A (cg-RX-API-DMAC10.html)
PT (1) PT76195B (cg-RX-API-DMAC10.html)
SE (1) SE460948B (cg-RX-API-DMAC10.html)
ZA (1) ZA83742B (cg-RX-API-DMAC10.html)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3576120D1 (de) * 1984-06-09 1990-04-05 Hoechst Ag Insulinzubereitungen, verfahren zu deren herstellung und deren verwendung.
JP2520262B2 (ja) * 1987-08-21 1996-07-31 春幸 川原 パツチテスト材料
US4789660A (en) * 1987-09-10 1988-12-06 American Home Products Corporation Insulin administration using methyl and propyl paraben
US5130298A (en) * 1989-05-16 1992-07-14 Ethicon, Inc. Stabilized compositions containing epidermal growth factor
US5534488A (en) * 1993-08-13 1996-07-09 Eli Lilly And Company Insulin formulation
US5474978A (en) * 1994-06-16 1995-12-12 Eli Lilly And Company Insulin analog formulations
YU18596A (sh) * 1995-03-31 1998-07-10 Eli Lilly And Company Analogne formulacije monomernog insulina
WO1997017945A2 (en) * 1995-11-13 1997-05-22 Minimed, Inc. Methods and compositions for the delivery of monomeric proteins
EP0891419A4 (en) * 1996-03-12 2000-03-01 Life Technologies Inc NUTRIENT ADDITIVE FOR HEMATOPOETIC CELL CULTURES
ES2218622T3 (es) * 1996-07-26 2004-11-16 Aventis Pharma Deutschland Gmbh Derivados de insulina con actividad de union al zinc incrementada.
CO4750643A1 (es) * 1997-06-13 1999-03-31 Lilly Co Eli Formulacion estable de la insulina que contiene l-arginina y protamina
SI0884053T1 (en) * 1997-06-13 2003-02-28 Eli Lilly And Company Stable insulin formulations
CN1278737A (zh) * 1997-11-12 2001-01-03 阿尔萨公司 减少多肽自结合的方法
DE19825447A1 (de) 1998-06-06 1999-12-09 Hoechst Marion Roussel De Gmbh Neue Insulinanaloga mit erhöhter Zinkbildung
PT1121144E (pt) * 1998-10-16 2002-11-29 Novo Nordisk As Preparados de insulina concentrada estavel para administracao pulmonar
DE19930676B4 (de) * 1999-07-02 2006-01-19 Sanofi-Aventis Deutschland Gmbh Verfahren zur Stabilisierung von Insulin, Insulinderivaten und/oder deren Vorläufer in komplexen Mischungen bei deren Lagerung in wäßrigen Lösungsmitteln
DK1265630T3 (da) * 2000-03-24 2006-10-09 Genentech Inc Anvendelse af insulin til behandling af brusksygdomme
JP4147234B2 (ja) * 2004-09-27 2008-09-10 キヤノン株式会社 吐出用液体、吐出方法、カートリッジ及び吐出装置
EP1506230B1 (en) 2002-05-07 2011-01-19 Novo Nordisk A/S Soluble formulations comprising monomeric insulin and acylated insulin
DE60317565T2 (de) * 2002-12-20 2008-09-11 Novo Nordisk A/S Pharmazeutische zusammensetzungen mit insulin und insulin-hexamer-liganden
US20050065066A1 (en) * 2002-12-20 2005-03-24 Kaarsholm Niels Christian Stabilised insulin compositions
WO2004096266A1 (en) * 2003-05-02 2004-11-11 Novo Nordisk A/S Improved physical stability of insulin formulations
WO2005012347A2 (en) * 2003-08-05 2005-02-10 Novo Nordisk A/S Novel insulin derivatives
RU2527893C2 (ru) * 2004-07-19 2014-09-10 Биокон Лимитед Инсулин-олигомерные конъюгаты, их препараты и применения
DK1969004T3 (da) * 2005-12-28 2011-11-28 Novo Nordisk As Insulinsammensætninger og metode til at lave en sammensætning
US20090136538A1 (en) * 2006-05-22 2009-05-28 Jan Jezek Stable vaccine formulation
GB0700523D0 (en) * 2007-01-11 2007-02-21 Insense Ltd The Stabilisation Of Proteins
CA2681158C (en) 2007-03-13 2018-09-18 Nutrition 21, Inc. Methods and compositions for the sustained release of chromium
US9034818B2 (en) * 2007-06-13 2015-05-19 Novo Nordisk A/S Pharmaceutical formulations comprising an insulin derivative
WO2009002867A2 (en) 2007-06-26 2008-12-31 Nutrition 21, Inc. Multiple unit dosage form having a therapeutic agents in combination with a nutritional supplement
PT2597103T (pt) * 2007-11-16 2017-02-08 Novo Nordisk As Composições farmacêuticas contendo insulina e um péptido insulinotrófico
EP2341940A1 (en) * 2008-07-16 2011-07-13 Arecor Limited The stabilisation of proteins
EP2328607A1 (en) * 2008-07-16 2011-06-08 Arecor Limited Stable formulation of a therapeutic protein
BRPI0919946A2 (pt) * 2008-10-30 2016-02-16 Novo Nordisk As tratamento de diabetes melito usando injeções de insulina com frequência de injeção menor que diariamente
US9060927B2 (en) 2009-03-03 2015-06-23 Biodel Inc. Insulin formulations for rapid uptake
HRP20191793T1 (hr) 2010-10-27 2019-12-27 Novo Nordisk A/S Liječenje dijabetesa melitusa injekcijama inzulina koje se primijenjuje u različitim intervalima injiciranja
US8933022B2 (en) 2011-03-01 2015-01-13 Jds Therapeutics, Llc Methods and compositions for the treatment and prevention Hypoglycemia and related disorders
DK2919804T3 (en) 2012-11-13 2018-05-14 Adocia Rapidly acting insulin formulation comprising a substituted anionic compound
NZ707160A (en) * 2012-12-19 2016-08-26 Wockhardt Ltd A stable aqueous composition comprising human insulin or an analogue or derivative thereof
AU2013368990B2 (en) 2012-12-26 2017-05-18 Wockhardt Limited Pharmaceutical composition
TWI780236B (zh) * 2013-02-04 2022-10-11 法商賽諾菲公司 胰島素類似物及/或胰島素衍生物之穩定化醫藥調配物
US10137172B2 (en) 2013-04-30 2018-11-27 Novo Nordisk A/S Administration regime
EP3077414B1 (en) * 2013-12-04 2020-06-17 Merck Sharp & Dohme Corp. Method for preparing crystalline insulin
TW201630622A (zh) 2014-12-16 2016-09-01 美國禮來大藥廠 速效胰島素組合物
JO3749B1 (ar) 2015-08-27 2021-01-31 Lilly Co Eli تركيبات إنسولين سريعة المفعول
WO2017139337A1 (en) 2016-02-11 2017-08-17 Nutrition 21, Llc Chromium containing compositions for improving health and fitness
JP7145849B2 (ja) 2016-09-29 2022-10-03 アレコル リミテッド 新規の製剤
MA50496A (fr) 2017-06-01 2020-09-09 Lilly Co Eli Compositions d'insuline à action rapide
US10335464B1 (en) 2018-06-26 2019-07-02 Novo Nordisk A/S Device for titrating basal insulin
US12343383B2 (en) 2019-07-12 2025-07-01 Novo Nordisk A/S High concentration insulin formulation
CN120142500B (zh) * 2025-02-28 2025-10-10 中国计量科学研究院 一种具有互换性的活性人胰岛素溶液标准物质及其制备方法和应用

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2882202A (en) * 1950-04-05 1959-04-14 Novo Terapeutisk Labor As Insulin crystal preparations and methods of producing them
US2787575A (en) * 1950-11-22 1957-04-02 Organon Zinc-glycine-insulin composition and production thereof
US2882203A (en) * 1951-06-26 1959-04-14 Novo Terapeutisk Labor As Injectable insulin preparation with protracted effect
DE1044360B (de) * 1953-08-19 1958-11-20 Roskilde Medical Company Ltd R Verfahren zur Herstellung von Zinkinsulin mit erhoehtem Zinkgehalt
DE956098C (de) * 1954-02-18 1957-01-10 Dr Dr Guenther Weitzel Verfahren zur Herstellung zinkreicher Insulin-Komplexverbindungen
US3058885A (en) * 1957-06-08 1962-10-16 Novo Terapeutisk Labor As Process for treatment of insulin crystals and for production of insulin preparationstherefrom
US3014842A (en) * 1957-08-10 1961-12-26 Novo Terapeutish Lab A S Injectable bovine insulin crystal suspensions and process of producing same
US3091573A (en) * 1958-05-12 1963-05-28 Novo Terapeutisk Labor As Quick acting insulin preparation
FR1263220A (fr) * 1958-08-01 1961-06-09 Novo Terapeutisk Labor As Procédé de production d'une préparation d'insuline à action rapide
DK116527B (da) * 1967-03-01 1970-01-19 Nordisk Insulinlab Fremgangsmåde til fremstilling af en hurtigtvirkende, holdbar, neutral opløsning af rent krystallinsk okseinsulin eller okseinsulin, der ved tilsætning af Zn er krystalliserbart i vand, eller blandinger af okseinsulin og insulin af anden oprindelse.
GB1285023A (en) * 1968-08-09 1972-08-09 Novo Terapeutisk Labor As Improvements in or relating to injectable insulin preparations
US3657425A (en) * 1969-03-12 1972-04-18 Burroughs Wellcome Co Beef insulin preparations
DE2459515C3 (de) * 1974-12-17 1982-02-11 Hoechst Ag, 6000 Frankfurt Arzneimittelzubereitungen mit antidiabetischer Wirkung
DE3064888D1 (en) * 1979-04-30 1983-10-27 Hoechst Ag Aqueous solutions of proteins stable against denaturization, process for their manufacture, and their utilization
DK80781A (da) * 1980-02-29 1981-08-30 Hospital For Sick Children Oploesninger af polypeptider
ES520249A0 (es) * 1982-03-03 1984-04-16 Nordisk Insulinlab Procedimiento de producir preparaciones de insulina.

Also Published As

Publication number Publication date
PT76195B (en) 1986-01-27
FR2521009B1 (fr) 1987-07-17
LU84632A1 (fr) 1983-09-08
JPS58192818A (ja) 1983-11-10
IE54548B1 (en) 1989-11-08
AU1113683A (en) 1983-08-11
JPH0367056B2 (cg-RX-API-DMAC10.html) 1991-10-21
FR2521009A1 (fr) 1983-08-12
AU549981B2 (en) 1986-02-20
ES519533A0 (es) 1984-10-16
DE3303860C2 (cg-RX-API-DMAC10.html) 1989-12-28
FI830375L (fi) 1983-08-06
FI78616B (fi) 1989-05-31
NO161204B (no) 1989-04-10
IE830220L (en) 1983-08-05
BE895832A (fr) 1983-08-04
NL8300440A (nl) 1983-09-01
GB2114573A (en) 1983-08-24
NO161204C (no) 1989-07-19
SE8300598D0 (sv) 1983-02-04
NZ203189A (en) 1985-07-31
IT1178455B (it) 1987-09-09
NL187269B (nl) 1991-03-01
GR77388B (cg-RX-API-DMAC10.html) 1984-09-11
SE460948B (sv) 1989-12-11
AT382780B (de) 1987-04-10
ZA83742B (en) 1983-11-30
SE8300598L (sv) 1983-08-06
ES8500060A1 (es) 1984-10-16
US4476118A (en) 1984-10-09
NO830385L (no) 1983-08-08
FI830375A0 (fi) 1983-02-03
DE3303860A1 (de) 1983-08-18
CA1203476A (en) 1986-04-22
ATA38983A (de) 1986-09-15
IT8319420A0 (it) 1983-02-04
GB8303133D0 (en) 1983-03-09
NL187269C (nl) 1991-08-01
GB2114573B (en) 1985-05-01
PT76195A (en) 1983-03-01
FI78616C (fi) 1989-09-11

Similar Documents

Publication Publication Date Title
DE3303860C2 (cg-RX-API-DMAC10.html)
AT408611B (de) Insulinanalogon-protamin-komplex
EP0357978B1 (de) Pharmazeutische Zubereitung zur Behandlung des Diabetes mellitus
DE69428860T2 (de) Insulin Formulierung
DE3240177C2 (cg-RX-API-DMAC10.html)
DE69434963T2 (de) Selektiv auf die leber wirkende pharmazeutisch aktive substanz
AT408720B (de) Parenterale pharmazeutische formulierung eines humaninsulinanalogon-komplexes
DE69834956T2 (de) Stabile Insulinformulierungen
CH652031A5 (de) Stabilisierte insulinpraeparate und verfahren zu deren herstellung.
DE69708121T3 (de) Halogenid-enthaltende insulinzubereitungen
DE69115590T2 (de) 4-Chinolonderivate mit einem zweiwertigen Metallion komplexiert enthaltende Zusammensetzung
DE2415101A1 (de) Pharmazeutische zusammensetzungen
DE3837825A1 (de) Neue insulinderivate, ihre verwendung und eine sie enthaltende pharmazeutische zubereitung
EP0012156A1 (de) Immunserumglobulin (ISG)-Präparate und Verfahren zu ihrer Herstellung
WO2001060394A1 (de) Stabile, nasal, oral oder sublingual anwendbare pharmazeutische zubereitung
DE10018783A1 (de) Lagerstabile Infusionslösung des Ciprofloxacins mit verringertem Säuregehalt
DE3717370A1 (de) Mischkristalle aus insulin und insulinderivaten, verfahren zur herstellung dieser mischkristalle, diese mischkristalle enthaltende pharmazeutische mittel und ihre verwendung zur behandlung von diabetes mellitus
EP0166971B1 (de) Insulinzubereitungen, Verfahren zu deren Herstellung und deren Verwendung
DE602005002495T2 (de) Injizierbare Formulierung mit Natriumdiclofenac, Beta-Cyclodextrin und einem Polysorbat
DE69426385T2 (de) Präparate für die Wundheilung, die Iod und einen Zucker enthalten
DE1212679B (de) Verfahren zur Herstellung von Insulinloesungen
DE3411104A1 (de) Zusammensetzung zur verringerung des augeninnendruckes
AT401469B (de) Pharmazeutische wässrige lösung zur parenteralen anwendung enthaltend einen in situ gebildeten komplex von einem alkaloid mit bis-indol-gerüst, sowie verfahren zu deren herstellung
DE60001489T2 (de) Pharmazeutische zubereitung für die intravenöse oder intramuskuläre verabreichung von octreotid
DE2427732A1 (de) Mittel zum anaesthesieren von saeugetieren

Legal Events

Date Code Title Description
PL Patent ceased